ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome

This study has been completed.
Study NCT00004832.   Last updated on June 23, 2005.   Information provided by FDA Office of Orphan Products Development

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Lambert-Eaton Myasthenic Syndrome
2 Additional conditions recognized in this trial
Syndrome
3 More general conditions related to this trial
Autoimmune Diseases
Autoimmune Diseases of the Nervous System
Disease
Immune System Diseases
Neoplasms
Neoplasms by Site
Nervous System Diseases
Nervous System Neoplasms
Neurodegenerative Diseases
Neuromuscular Diseases
Neuromuscular Junction Diseases
Paraneoplastic Syndromes
Paraneoplastic Syndromes, Nervous System
Pathologic Processes
4 Interventions listed in this trial
3,4-diaminopyridine
5 Additional drug interventions recognized in this trial
4-Aminopyridine
6 More general drug interventions related to this trial
Cardiovascular Agents
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Potassium Channel Blockers
Therapeutic Uses
7 Sponsors listed in this trial
FDA Office of Orphan Products Development
Duke University




Links to all studies - primarily for crawlers